| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/09/1995 | US5413791 Collagen-polymer conjugates |
| 05/04/1995 | WO1995011699A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| 05/04/1995 | WO1995011694A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 05/04/1995 | WO1995011671A1 Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients |
| 05/04/1995 | WO1995011669A1 Suspension of loteprednol etabonate |
| 05/04/1995 | WO1995006077A3 Polymeric matrices and their uses in pharmaceutical compositions |
| 05/03/1995 | EP0650368A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 05/03/1995 | EP0650365A1 Biocidal composition containing mustard seed plant extract. |
| 05/03/1995 | EP0650361A1 Compositions for the treatment of arthritis containing phosphonates and nsaids |
| 05/03/1995 | EP0650355A1 Medicaments for the treatment of visceral pain and migraine |
| 05/03/1995 | EP0569541B1 Growth factor containing matrix for the treatment of cartilage lesions |
| 05/03/1995 | EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives |
| 04/30/1995 | CA2134610A1 Compositions containing piperine |
| 04/27/1995 | WO1995011029A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/27/1995 | WO1995011016A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 04/27/1995 | WO1995011013A2 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 04/27/1995 | WO1995010999A1 Novel composition |
| 04/27/1995 | WO1995002409A3 Use of vitamin d and derivatives thereof for the manufacture of a medicament for protection against neuron loss |
| 04/27/1995 | CA2173333A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/26/1995 | EP0649658A1 Method of tumor treatment |
| 04/26/1995 | EP0649657A1 Pharmaceutical combinations containing a NSAID and an opioid analgesic |
| 04/26/1995 | EP0649654A1 Use of a combination of an ACE-inhibitor with a calcium antagonist in the treatment of proteinuria |
| 04/26/1995 | EP0649650A1 Bioadhesive pharmaceutical composition for controlled release of drugs |
| 04/26/1995 | EP0521070B1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
| 04/25/1995 | CA1335346C Method of treating erectile dysfunction |
| 04/20/1995 | WO1995010275A1 Use of alpha receptor antagonists for the treatment of chronic muscle pain |
| 04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/1995 | WO1995010267A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 04/20/1995 | WO1995010185A1 Superoxide dismutase and mimetics thereof |
| 04/20/1995 | DE4335454A1 Geriatric medical composition |
| 04/20/1995 | CA2173738A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 04/19/1995 | EP0648502A1 Live vaccine with enhanced stability |
| 04/19/1995 | EP0648495A2 Cation-complexed polysaccharides |
| 04/19/1995 | EP0648488A1 Method to alter hairgrowth and compositions therefor |
| 04/19/1995 | EP0648118A1 Methods and products for treating presbyopia |
| 04/19/1995 | EP0648114A1 Liposomes, method of preparing them and their use in the preparation of drugs. |
| 04/19/1995 | EP0624096A4 Taxol as a radiation sensitizer. |
| 04/19/1995 | EP0407392B1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
| 04/19/1995 | EP0243446B1 Alpha tocopherol-based vesicles |
| 04/18/1995 | US5407935 Pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonist |
| 04/18/1995 | US5407922 Certain N-substituted-amino-alkane phosphinic acid derivatives having anti-epileptic properties |
| 04/18/1995 | US5407821 Genetic diagnosis of torsion dystonia |
| 04/18/1995 | US5407688 Compositions and methods for treating gastrointestinal disorders |
| 04/18/1995 | CA1335259C Composition of spent liquor from pulping process for antiviral medicine |
| 04/13/1995 | WO1995009654A1 Gene therapy of the nervous system |
| 04/13/1995 | WO1995009652A1 Treatment of autoimmune and inflammatory disorders |
| 04/13/1995 | WO1995009621A1 Pharmaceutical compositions containing nitric oxide synthase inhibitors and anti-cancer agents |
| 04/13/1995 | WO1995009614A1 Pharmaceutical composition |
| 04/13/1995 | WO1995009609A1 New emulsion formulation |
| 04/13/1995 | WO1995009607A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 04/13/1995 | WO1995005167A3 Treatment of adverse effects associated with administration of extracellular hemoglobin |
| 04/13/1995 | CA2173111A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 04/13/1995 | CA2172143A1 New emulsion formulation |
| 04/13/1995 | CA2171109A1 Gene therapy of the nervous system |
| 04/13/1995 | CA2167413A1 Pharmaceutical composition |
| 04/12/1995 | EP0647448A1 Orally administrable opioid formulations having extended duration of effect |
| 04/12/1995 | EP0647444A1 L-2-oxothiazolidine-4-carboxylate and other stimulators of intracellular glutathione synthesis for reducing or preventing bone marrow hypoplasia |
| 04/12/1995 | EP0647137A1 Glycine receptor antagonists and the use thereof |
| 04/12/1995 | EP0487520B1 Compressed powder medicaments |
| 04/11/1995 | US5405990 Chemical compounds |
| 04/11/1995 | US5405850 Antiviral compositions consisting of acyclovir and a 2-acetyl pyridine derivative |
| 04/11/1995 | US5405846 Mixture of 15-deoxyprostaglandin and adrenergic blocking agent |
| 04/11/1995 | US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin |
| 04/11/1995 | CA1335175C Methods and compositions for the treatment of lung conditions |
| 04/06/1995 | WO1995009365A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 04/06/1995 | WO1995009002A1 Methods of inhibiting phagocytosis |
| 04/06/1995 | WO1995008993A1 Oral formulations of an antifungal |
| 04/06/1995 | CA2172961A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 04/05/1995 | EP0646008A1 Minimizing progestin associated breakthrough bleeding |
| 04/05/1995 | CA2133401A1 Live vaccine having an increased stability |
| 04/04/1995 | US5403847 Use of α1C specific compounds to treat benign prostatic hyperlasia |
| 04/04/1995 | US5403830 Compositions and methods of treating gastrointestinal disorders |
| 04/04/1995 | US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label |
| 03/30/1995 | WO1995008563A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 03/30/1995 | WO1995008562A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
| 03/30/1995 | WO1995008350A1 REGULATION OF bcl-2 GENE EXPRESSION |
| 03/30/1995 | WO1995008334A1 Antimalarial |
| 03/30/1995 | WO1995008326A1 Protein kinase c activators and their use in decreasing expression of cell antigens |
| 03/30/1995 | CA2172383A1 Protein kinase c activators and their use in decreasing expression of cell antigens |
| 03/30/1995 | CA2171607A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
| 03/30/1995 | CA2148607A1 Antimalarial drug |
| 03/29/1995 | EP0645390A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation |
| 03/29/1995 | EP0645167A1 Process for obtaining pharmacological active compounds from complex substance mixtures |
| 03/29/1995 | EP0645142A1 A novel physiologically active substance |
| 03/28/1995 | US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment |
| 03/28/1995 | CA2029046C Sustained release compositions for treating periodontal disease |
| 03/25/1995 | WO1999013871A2 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 03/23/1995 | WO1995007985A1 Eotaxin: eosinophil chemotactic cytokine |
| 03/23/1995 | WO1995007716A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 03/23/1995 | WO1995007700A1 Method for protection against genotoxic mutagenesis |
| 03/23/1995 | WO1995007691A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 03/23/1995 | WO1995007690A1 Composition and method for treating nicotine craving in smoking cessation |
| 03/23/1995 | WO1994028897A3 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
| 03/23/1995 | CA2171955A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 03/23/1995 | CA2132568A1 Pharmaceutical compositions and usages |
| 03/22/1995 | EP0643971A2 Antifungal compositions consisting of an antifungal agent, e.g. antibiotic R-106I, and a fungal MDR inhibitor |
| 03/22/1995 | EP0643775A1 Therapeutic compositions |
| 03/22/1995 | EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 03/22/1995 | EP0643581A1 Ocular androgen therapy in sjögren's syndrome |
| 03/22/1995 | EP0643580A1 Combinations of ace inhibitors and diuretics |